BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
4.110
-0.220 (-5.08%)
At close: Dec 5, 2025, 4:00 PM EST
4.090
-0.020 (-0.49%)
After-hours: Dec 5, 2025, 7:52 PM EST
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $7.38 million as of December 5, 2025. Its market cap has increased by 43.89% in one year.
Market Cap
7.38M
Enterprise Value
4.72M
1-Year Change
43.89%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $7.38M, a decrease of -82.47%. That is a compound annual growth rate of -28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 7.38M | 46.92% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 191.05B |
| BHP Group | 143.95B |
| Rio Tinto Group | 125.19B |
| Southern Copper | 113.52B |
| Newmont | 97.83B |
| Agnico Eagle Mines | 84.94B |
| The Sherwin-Williams Company | 83.61B |
| CRH plc | 81.34B |